Opinion
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Goldstein_Sidney_web.jpg)
Entresto, inpatient therapy, and surrogate markers
- Author:
- Sidney Goldstein, MD
One overriding factor behind the slow uptake of Entresto for heart failure may be the cost of the drug compared to enalapril.
Opinion
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Goldstein_Sidney_web.jpg)
Are guidelines relevant?
- Author:
- Sidney Goldstein, MD
RCTs represent a very special subset of any disease process but they are the best we can do.
Opinion
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Goldstein_Sidney_web.jpg)
Who’s increasing health care costs? Not us!
- Author:
- Sidney Goldstein, MD
Community leadership has been minimized, and where it exists, it is under constant pressure to make a profit.
Opinion
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Goldstein_Sidney_web.jpg)
Medical ethics and economics
- Author:
- Sidney Goldstein, MD
It’s up to physicians to build an ethical wall between interests in clinical research.
News
The end of aspirin for primary prevention
- Author:
- Sidney Goldstein, MD
Aspirin for the primary prevention of cardiovascular events is dead, so why does the CDC keep pushing it?...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Goldstein_Sidney_web.jpg)
Heart cell transplant rejections
- Author:
- Sidney Goldstein, MD
Piero Anversa’s fraudulent research led to an NIH study in humans that is still ongoing.
Opinion
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Goldstein_Sidney_web.jpg)
I’M NOT A PROVIDER
- Author:
- Sidney Goldstein, MD
Health care isn’t a commodity, and patients aren’t customers. We’re not talking about shoes.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Goldstein_Sidney_web.jpg)
On cardiology training
- Author:
- Sidney Goldstein, MD
I recently received a letter from a former fellow who completed his training almost 25 years ago, thanking me for guiding him through his...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Goldstein_Sidney_web.jpg)
‘If this is an emergency, call 911’
- Author:
- Sidney Goldstein, MD
Or, don’t even try speaking directly your doctor.
Opinion
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Goldstein_Sidney_web.jpg)
Beta-blocker therapy post AMI
- Author:
- Sidney Goldstein, MD
Stick with beta-blocker therapy until evidence shows why not to use it.
Opinion
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Goldstein_Sidney_web.jpg)
CMS clinical trials raise cardiac mortality
- Author:
- Sidney Goldstein, MD
Health agencies should take their cues from randomized clinical trial designs to avoid unintended consequences.
Article
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Goldstein_Sidney_web.jpg)
PCI or CABG in the high-risk patient
- Author:
- Sidney Goldstein, MD
The recent report from the SYNTAX trials should give pause to our interventionalist colleagues embarking on multiple angioplasty and stenting...
Article
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Goldstein_Sidney_web.jpg)
TOPCAT, a third time around
- Author:
- Sidney Goldstein, MD
TOPCAT is back again, having randomized its first patient with heart failure with preserved ejection fraction (HFpEF) almost 10 years ago for its...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/images/article_teasers/media_4593fbb193f518f3ac_Goldstein_Sidney.jpg)
Medical quality beats patient comfort
- Author:
- Sidney Goldstein, MD
News
The new heart failure: A call for new research initiatives
- Author:
- Sidney Goldstein, MD
Progress in treating ischemic heart disease has resulted in more patients with heart failure, and we must work to develop more effective heart...